281 related articles for article (PubMed ID: 31557072)
21. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
22. Prucalopride.
Frampton JE
Drugs; 2009; 69(17):2463-76. PubMed ID: 19911858
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the efficacy of prucalopride (resolor) in the treatment of patients with chronic constipation].
Osipenko MF; Bikbulatova EA; Skalinskaia MA; Kulygina IuA; Pankova LIu
Ter Arkh; 2013; 85(12):60-4. PubMed ID: 24640670
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.
Müller-Lissner S
Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):391-401. PubMed ID: 23425050
[TBL] [Abstract][Full Text] [Related]
25. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating.
Staller K; Hinson J; Kerstens R; Spalding W; Lembo A
Am J Gastroenterol; 2022 Jan; 117(1):184-188. PubMed ID: 34585675
[TBL] [Abstract][Full Text] [Related]
27. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
Ford AC; Suares NC
Gut; 2011 Feb; 60(2):209-18. PubMed ID: 21205879
[TBL] [Abstract][Full Text] [Related]
28. The use of Resolor (prucalopride) for chronic constipation in women.
Woodward S
Br J Nurs; 2012 Sep 13-26; 21(16):982, 984-6. PubMed ID: 23123655
[TBL] [Abstract][Full Text] [Related]
29. Effect of prucalopride on symptoms of chronic constipation.
Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
[TBL] [Abstract][Full Text] [Related]
30. Prucalopride: For functional constipation only?
Bellini M; Gambaccini D; Bassotti G
Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
[TBL] [Abstract][Full Text] [Related]
32. What role for prucalopride in constipation?
Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
[TBL] [Abstract][Full Text] [Related]
33. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
34. Prucalopride for chronic constipation.
Lacy BE; Loew B; Crowell MD
Drugs Today (Barc); 2009 Dec; 45(12):843-53. PubMed ID: 20135019
[TBL] [Abstract][Full Text] [Related]
35. Clinical Outcomes Before and After Prucalopride Treatment: An Observational Study in Patients With Chronic Idiopathic Constipation in the United States.
Lembo A; Cash BD; Lu M; Terasawa E; Terreri B; Du S; Ayyagari R; Feuerstadt P; Moshiree B; Westermeyer B; Pi S; Boules M
Clin Transl Gastroenterol; 2024 May; 15(5):e00687. PubMed ID: 38357940
[TBL] [Abstract][Full Text] [Related]
36. Prucalopride. In chronic constipation: poorly documented risks.
Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
[TBL] [Abstract][Full Text] [Related]
38. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
Cinca R; Chera D; Gruss HJ; Halphen M
Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
[TBL] [Abstract][Full Text] [Related]
39. Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation.
Tameez Ud Din A; Khan AH; Bajwa H; Maqsood MH; Malik MN
Cureus; 2019 Apr; 11(4):e4382. PubMed ID: 31218146
[TBL] [Abstract][Full Text] [Related]
40. Pharmacoeconomic study of chronic constipation in a secondary care centre.
Walsh C; Murphy J; Quigley EM
Ir J Med Sci; 2015 Dec; 184(4):863-70. PubMed ID: 25287934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
